VeroScience Continues to Explore Clinical Benefits of Circadian Neuroendocrine Resetting Therapy with Six Papers Presented at 2016 American Diabetes Association Scientific Sessions June 1014

Press/Media: Press / Media

PeriodJun 11 2016

Media coverage

1

Media coverage

  • TitleVeroScience Continues to Explore Clinical Benefits of Circadian Neuroendocrine Resetting Therapy with Six Papers Presented at 2016 American Diabetes Association Scientific Sessions June 1014
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date6/11/16
    PersonsRalph A Defronzo
View all 1
View less